[1] Friedman PC. Management of Difficult-to-Treat Warts: Traditional and New Approaches. Am J Clin Dermatol. 2021 Jan 11. doi: 10.1007/s40257-020-00582-4.
[2] Maronn M, Salm C, Lyon V, Galbraith S. One-year experience with candida antigen immunotherapy for warts and molluscum. Pediatr Dermatol. 2008;25(2):189–92.
[3] Chia-Han Yeh M, Tsai T, Huang Y. Intralesional vitamin D3 injection in the treatment of warts: a systematic review and meta-analysis. J Am Acad Dermatol. 2019.
[4] Broganelli P, Chiaretta A, Fragnelli B, Bernengo MG. Intralesional cidofovir for the treatment of multiple and recalcitrant cutaneous viral warts. Dermatol Ther. 2012;25(5):468–71.
[5] Fernandez-Morano TJB, Gonzalez-Carrascosa M, Tortajada BMT. Topical cidofovir for viral warts in children. J Eur Acad Dermatol Venereol. 2011;25(12):1487–9.
[6] Bik L, Sangers T, Greveling K, Prens E, Haedersdal M, van Doorn M. Efficacy and tolerability of intralesional bleomycin in dermatology: a systematic review. J Am Acad Dermatol. 2020;83(3):888–903.
[7] Kaul S, Caldito EG, Jakhar D, Kaur I, Kwatra SG, Mehta S. Comparative efficacy and safety of intralesional bleomycin relative to topical bleomycin with microneedling in the treatment of warts: a systematic review. J Am Acad Dermatol. 2020.
[Edward Lain MD, Brenda LaTowsky MD, Lesley Loss MDGMM. A prospective, non-randomized, multicenter pivotal study of nano-pulse stimulation (NPS) for treatment of cutaneous non-genital warts. In: American Society for Dermatologic Surgery, annual meeting; 2020.
